You just read:

Kleo Pharmaceuticals Presents Preclinical Data Supporting Development of its CD38-ARM™, a Novel Immuno-therapeutic, at American Society of Hematology (ASH) Annual Meeting

News provided by

Kleo Pharmaceuticals, Inc.

Nov 06, 2019, 09:02 ET